Carvedilol linked to lower cirrhosis complication risk

1. In this retrospective cohort study, carvedilol was associated with a lower risk of major liver decompensation compared with nadolol and propranolol. 2. Carvedilol was also associated with lower risks of individual decompensation outcomes, including ascites, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome (HRS). Evidence Rating Level: 2 (Good) Study Rundown: Nonselective…